-
- Target See all HHV8 products
- HHV8 (Herpes Virus Type 8 (HHV8))
-
Reactivity
- Human
-
Host
- Rat
-
Clonality
- Monoclonal
-
Conjugate
- This HHV8 antibody is un-conjugated
-
Application
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Cross-Reactivity (Details)
- Species reactivity (tested):Human.
- Purification
- Purified
- Immunogen
- Recombinant protein corresponding to the latent nuclear antigen-1 molecule of HHV8.
- Clone
- LN53
- Isotype
- IgG2c
-
anti-Herpes Virus Type 8 (HHV8) (C-Term) antibody
HHV8 Reactivity: Human WB, EIA Host: Rabbit Polyclonal unconjugated
-
- Application Notes
-
Immunohistochemistry: Use at 1/25-1/50 dilution in an ABC method (30 to 60 minutes atroom temperature). Formalin fixed paraffin embedded tissue sections require high temperature antigenunmasking with 10 mM citrate buffer, pH 6.0 prior to immunostaining. Recommended Positive Control: Kaposi's sarcoma.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Sodium Azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C
- Storage Comment
- Store the antibody undiluted at 2-8 °C.
-
- Target
- HHV8 (Herpes Virus Type 8 (HHV8))
- Alternative Name
- Herpes Virus Type 8 / HHV8 (HHV8 Products)
- Target Type
- Virus
- Background
- HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.Synonyms: HHV-8, KHSV
-
You are here:
